An aberrant expression of BUB1B had been reported in various cancers including ductal breast carcinoma (DBC) [11], glioblastoma (GBM) [12], and pancreatic ductal adenocarcinoma (PDAC) [13]. Here, BUB1B is linked to breast ductal adenocarcinoma.